drugset / Trial / NCT03432689

Cycloserine rTMS Plasticity Augmentation

NCT03432689

Phase 1 Completed 12 enrolled University of Calgary
RandomizedCrossoverQuadruple-blindBasic science

Summary

Transcranial magnetic stimulation (rTMS) is an investigational and therapeutic modality that impacts the connection strength between neurons by delivering patterned energy. In response to this patterned energy neurons fire and adapt by changing their connection strengths. This change in connection strengths is believed to be the underlying mechanism whereby this intervention has therapeutic benefit for this intervention in conditions such as depression. The purpose of this study is to test a means of enhancing the effect of rTMS using a medication (cycloserine) that has been shown to augment and stabilize activity dependent neuronal changes. The investigators wish to use the motor system, where the associated muscle response to brain stimulation can be measured, to probe activity dependent changes in connection strength between neurons.

Timeline

Start
2018-08-06
Primary completion
2018-11-07
Completion
2018-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule 100 mg Oral

Indications

No indication recorded.